Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion.
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2017 03 09; 2(5):e90772.